Chargement en cours...
Progress in Developing Virus-like Particle Influenza Vaccines
Recombinant vaccines based on virus-like particles (VLPs) or nanoparticles have been successful in their safety and efficacy in preclinical and clinical studies. The technology of expressing enveloped VLP vaccines has combined with molecular engineering of proteins in membrane-anchor and immunogenic...
Enregistré dans:
| Publié dans: | Expert Rev Vaccines |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5093318/ https://ncbi.nlm.nih.gov/pubmed/27058302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14760584.2016.1175942 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|